These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29616162)

  • 21. Sudden vision loss and neurological deficits after facial hyaluronic acid filler injection.
    Lucaciu A; Samp PF; Hattingen E; Kestner RI; Davidova P; Kohnen T; Rudolph J; Dietz A; Steinmetz H; Strzelczyk A
    Neurol Res Pract; 2022 Jul; 4(1):40. PubMed ID: 35850779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Hyaluronic Acid Filler-Induced Impending Necrosis With Hyaluronidase: Consensus Recommendations.
    Cohen JL; Biesman BS; Dayan SH; DeLorenzi C; Lambros VS; Nestor MS; Sadick N; Sykes J
    Aesthet Surg J; 2015 Sep; 35(7):844-9. PubMed ID: 25964629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyaluronidase: An overview of its properties, applications, and side effects.
    Jung H
    Arch Plast Surg; 2020 Jul; 47(4):297-300. PubMed ID: 32718106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nicolau syndrome due to hyaluronic acid injections.
    Andre P; Haneke E
    J Cosmet Laser Ther; 2016 Aug; 18(4):239-44. PubMed ID: 26963701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebral Angiographic Findings of Cosmetic Facial Filler-related Ophthalmic and Retinal Artery Occlusion.
    Kim YK; Jung C; Woo SJ; Park KH
    J Korean Med Sci; 2015 Dec; 30(12):1847-55. PubMed ID: 26713062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ischemic oculomotor nerve palsy due to hyaluronic acid filler injection.
    Bae IH; Kim MS; Choi H; Na CH; Shin BS
    J Cosmet Dermatol; 2018 Dec; 17(6):1016-1018. PubMed ID: 29607622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Intra-arterial and Subcutaneous Testicular Hyaluronidase Injection Treatments and the Vascular Complications of Hyaluronic Acid Filler.
    Wang M; Li W; Zhang Y; Tian W; Wang H
    Dermatol Surg; 2017 Feb; 43(2):246-254. PubMed ID: 27930375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal fossa defects: techniques for injecting hyaluronic acid filler and complications after hyaluronic acid filler injection.
    Juhász ML; Marmur ES
    J Cosmet Dermatol; 2015 Sep; 14(3):254-9. PubMed ID: 26311237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Retrobulbar Hyaluronidase in Filler-Associated Blindness: Evaluation of Fundus Perfusion and Electroretinogram Readings in an Animal Model.
    Hwang CJ; Mustak H; Gupta AA; Ramos RM; Goldberg RA; Duckwiler GR
    Ophthalmic Plast Reconstr Surg; 2019; 35(1):33-37. PubMed ID: 29877958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Managing Periocular Filler-Related Syndrome Prior to Lower Blepharoplasty.
    Zoumalan CI
    Aesthetic Plast Surg; 2019 Feb; 43(1):115-122. PubMed ID: 30298348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The study of histological changes of the arterial vascular structure after hyaluronidase exposure.
    Wattanakrai P; Jurairattanaporn N; Rojhirunsakool S; Visessiri Y; Suwanchinda A; Thanasarnaksorn W
    J Cosmet Dermatol; 2018 Aug; 17(4):632-636. PubMed ID: 30091219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Kinetics of Reversible Hyaluronic Acid Filler Injection Treated With Hyaluronidase.
    Juhász MLW; Levin MK; Marmur ES
    Dermatol Surg; 2017 Jun; 43(6):841-847. PubMed ID: 28498207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intralesional hyaluronidase injection to relieve non-hyaluronic acid filler-induced vascular adverse events.
    Kadouch J; Schelke L; Groh O; Sokol V; Velthuis P
    Int J Dermatol; 2024 Jul; ():. PubMed ID: 38955457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrasonography-guided Cannula Method for Hyaluronic Acid Filler Injection with Evaluation using Laser Speckle Flowgraphy.
    Iwayama T; Hashikawa K; Osaki T; Yamashiro K; Horita N; Fukumoto T
    Plast Reconstr Surg Glob Open; 2018 Apr; 6(4):e1776. PubMed ID: 29876194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous Hyaluronidase for Visual Loss Secondary to Filler Injection: A Novel Therapeutic Approach.
    Mccann M
    J Clin Aesthet Dermatol; 2019 Dec; 12(12):25-27. PubMed ID: 32038761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of impending necrosis associated with soft tissue filler injections.
    Dayan SH; Arkins JP; Mathison CC
    J Drugs Dermatol; 2011 Sep; 10(9):1007-12. PubMed ID: 22052269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute diplopia after glabellar hyaluronic acid filler injection.
    Chung CW; Shiuey EJ; Briceño CA; Lee V
    Am J Ophthalmol Case Rep; 2023 Sep; 31():101860. PubMed ID: 37251111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of glabella skin necrosis following injection of hyaluronic acid filler using platelet-rich plasma.
    Kang BK; Kang IJ; Jeong KH; Shin MK
    J Cosmet Laser Ther; 2016; 18(2):111-2. PubMed ID: 26052808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doppler Ultrasound in the Management of Vascular Complications Associated with Hyaluronic Acid Dermal Fillers.
    Munia MA; Munia CG; Parada MB; Ben-Hurferraz Parente J; Wolosker N
    J Clin Aesthet Dermatol; 2022 Feb; 15(2):40-43. PubMed ID: 35309877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitrous Oxide Improves Tissue Perfusion in Vascular Occlusion Management.
    Desyatnikova S; Mangieri L
    Plast Reconstr Surg Glob Open; 2023 Jul; 11(7):e5154. PubMed ID: 37496982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.